Literature DB >> 1460471

How should health status measures be assessed? Cautionary notes on procrustean frameworks.

J I Williams1, C D Naylor.   

Abstract

Mesh:

Year:  1992        PMID: 1460471     DOI: 10.1016/0895-4356(92)90195-s

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  7 in total

1.  On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.

Authors:  C B Terwee; F W Dekker; W M Wiersinga; M F Prummel; P M M Bossuyt
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

2.  On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis.

Authors:  M M Murawski; P A Miederhoff
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

3.  Quality-of-life assessment in respiratory disease: an examination of the content and validity of four questionnaires.

Authors:  M E Hyland
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

4.  A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam.

Authors:  Paul Maruff; John Werth; Bruno Giordani; Angela F Caveney; Douglas Feltner; Peter J Snyder
Journal:  Psychopharmacology (Berl)       Date:  2006-03-28       Impact factor: 4.530

5.  Violence victims' perception of functioning and well-being: a survey from an urban public hospital walk-in clinic.

Authors:  T Conway; T C Hu; C Warshaw; P Kim; A Bullon
Journal:  J Natl Med Assoc       Date:  1995-06       Impact factor: 1.798

6.  Individual-patient monitoring in clinical practice: are available health status surveys adequate?

Authors:  C A McHorney; A R Tarlov
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

Review 7.  Assessing quality-of-life outcomes in cardiovascular clinical research.

Authors:  Daniel B Mark
Journal:  Nat Rev Cardiol       Date:  2016-02-18       Impact factor: 32.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.